Purdue's Sacklers boost opioid settlement offer up to $6 billion

As part of the deal, Purdue will hand over nearly all of its assets to the states, cities and counties that are suing the drugmaker over its handling of the pain killer OxyContin

Members of the billionaire Sackler family that own Purdue Pharma LP have offered to pay as much as $6 billion to revive the OxyContin maker’s imperiled opioid settlement, a more-than $1 billion increase from their existing proposal.

The new settlement offer would see the Sackler family pay at least $5.5 billion, with additional money contingent on certain asset sales, a court appointed mediator, U.S. Bankruptcy Judge Shelley Chapman, said in a report Friday. A final deal hasn’t been reached, according to the mediator.

The Sacklers and a handful of state attorneys general have been in mediation for the past two months, after